Evidence map›Paper›PMID 32102133›Full record

ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2020

[Trend Analysis of Clinical Epidemiological Characteristics of Lung Cancer in Yunnan Cancer Hospital from 2005 to 2014].

Yanping Lin, Qiang Zhang, Yanni Lu, Yunchao Huang, Jie Ma, Yongchun Zhou

Open access · greenAbstract read
In one paragraph

Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Clinic information, pathological, and imaging characteristics in 2 058 surgical patients with lung cancer from a single center.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yanping LinDepartment of Yunnan Cancer Center, Yunnan Cancer Hospital/The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Center, Kunming 650118, China.
Qiang ZhangDepartment of Yunnan Cancer Center, Yunnan Cancer Hospital/The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Center, Kunming 650118, China.
Yanni LuDepartment of Yunnan Cancer Center, Yunnan Cancer Hospital/The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Center, Kunming 650118, China.
Yunchao HuangDepartment of Yunnan Cancer Center, Yunnan Cancer Hospital/The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Center, Kunming 650118, China.
Jie MaDepartment of Yunnan Cancer Center, Yunnan Cancer Hospital/The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Center, Kunming 650118, China.
Yongchun ZhouDepartment of Yunnan Cancer Center, Yunnan Cancer Hospital/The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Center, Kunming 650118, China.
Kunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundYunnan is a country with a high incidence of lung cancer in China and all over the world, and its morbidity and mortality are still rising. With changes in lifestyle and environment, the clinical epidemiological characteristics of lung cancer are converting. However, the trend of clinical characteristics of lung cancer in Yunnan has not been reported in the past 10 years, and we should start further research. The aim of this study was to explore the clinical characteristics and changes of lung cancer in Yunnan from 2005 to 2014, and to provide a theoretical basis for lung cancer prevention and treatment in this region.

methodsA retrospective survey was used to extract the cases of lung cancer patients who were treated in our hospital from 2005 to 2014 by simple random sampling. The sociodemographic and clinicopathological characteristics of the patients were extracted by using a unified and standardized questionnaire. And the statistical analysis of the data was performed.

resultsA total of 1,000 patients with lung cancer were enrolled, with an average age of (58.1±10.1) years, and the ratio of male to female was 3.08/1.00. The proportion of male patients decreased from 75.0% in 2005 to 66.0% in 2014, while female patients increased from 25.0% to 34.0% (P=0.007). The proportion of patients aged ≥60 years increased from 30.0% in 2005 to 39.0% in 2014, and the proportion of patients under 60 years of age decreased, but there was no statistical difference (P=0.532). The proportion of patients with lower levels of education (primary or junior high school) increased from 36.0% to 66.0% (P<0.001). The proportion of smokers decreased from 71.0% to 47.0%, and the number of non-smokers increased from 29.0% to 52.0% (P=0.003). The patients with advanced lung cancer (IIIb-IV) increased from 20.0% to 54.0%, while the proportion of stage II-IIIa decreased from 62.0% to 24.0% (P=0.002). The proportion of adenocarcinoma increased from 36.0% to 61.0%, while squamous cell carcinoma decreased from 32.0% to 27.0% (P<0.001). Chest X-ray applications decreased from 91.0% to 58.0% (P<0.001), while chest computed tomography (CT) usage increased from 46.0% to 89.0% (P<0.001). Head magnetic resonance imaging (MRI) usage increased from 1.0% to 15.0% (P<0.001). The bone scan increased from 35.0% to 78.0% (P<0.001). The positron emission tomography-CT (PET-CT) inspection technique increased significantly from 0.0% to 17.0%. Chemotherapy (P=0.67) and surgery (P=0.78) were the most common treatments and the treatments were unchanged over the past 10 years.

conclusionsThe proportion of female patients increased, the clinical stage was late, and the pathological type transformation was a major challenge in the prevention and treatment of lung cancer in Yunnan. Despite major changes in sociodemographic and clinicopathological features, the choice of primary treatment modalities has not changed, and further research is needed.

Indexed as

AgedChinaFemaleHospitalsHumansLung NeoplasmsMagnetic Resonance ImagingMaleMiddle AgedRetrospective StudiesClinical epidemiologyLung neoplasmasYunnan

Identifiers

PMID32102133
PMCPMC7118330
OpenAlexW3012696244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.